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Abstract
Background: GATA-2 is a transcription factor required for hematopoietic stem cell survival as
well as for neuronal development in vertebrates. It has been shown that specific expression of
GATA-2 in blood progenitor cells requires distal cis-acting regulatory elements. Identification and
characterization of these elements should help elucidating transcription regulatory mechanisms of
GATA-2 expression in hematopoietic lineage.
Results:  By pair-wise alignments of the zebrafish genomic sequences flanking GATA-2  to
orthologous regions of fugu, mouse, rat and human genomes, we identified three highly conserved
non-coding sequences in the genomic region flanking GATA-2, two upstream of GATA-2 and another
downstream. Using both transposon and bacterial artificial chromosome mediated germline
transgenic zebrafish analyses, one of the sequences was established as necessary and sufficient to
direct hematopoietic GFP expression in a manner that recapitulates that of GATA-2. In addition, we
demonstrated that this element has enhancer activity in mammalian myeloid leukemia cell lines,
thus validating its functional conservation among vertebrate species. Further analysis of potential
transcription factor binding sites suggested that integrity of the putative HOXA3 and LMO2 sites
is required for regulating GATA-2/GFP hematopoietic expression.
Conclusion: Regulation of GATA-2 expression in hematopoietic cells is likely conserved among
vertebrate animals. The integrated approach described here, drawing on embryological,
transgenesis and computational methods, should be generally applicable to analyze tissue-specific
gene regulation involving distal DNA cis-acting elements.
Background
The transcription factor GATA-2, which is expressed dur-
ing the earliest stages of hematopoiesis, is essential for
early hematopoietic development; GATA-2-/- mice have
severe anemia and are deficient in the proliferation and
survival of multipotent hematopoietic progenitors [1,2].
Published: 20 August 2007
BMC Developmental Biology 2007, 7:97 doi:10.1186/1471-213X-7-97
Received: 1 November 2006
Accepted: 20 August 2007
This article is available from: http://www.biomedcentral.com/1471-213X/7/97
© 2007 Yang et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Developmental Biology 2007, 7:97 http://www.biomedcentral.com/1471-213X/7/97
Page 2 of 13
(page number not for citation purposes)
Given the essential nature of GATA-2, the factors required
for its hematopoietic expression are likely to play an
important role in the initial stages of hematopoietic devel-
opment. Although a few growth factors that affect GATA-
2 expression are known [3,4], little is understood about
the regulation of GATA-2 in hematopoietic tissues. Recent
studies showed that Oct-1, GATA, and Evi1 factors and
their binding sites were involved in regulating GATA-2
hematopoietic expression [4-6]. However, these binding
sites are located in the proximal region of the promoter
and are unlikely sufficient in directing hematopoietic
expression of GATA-2 since several lines of evidence have
shown that the regulatory elements required for GATA-2
hematopoietic expression are located many kilobase pairs
(kbp) upstream of GATA-2 [7-9]. In fact, to fully rescue
hematopoietic development in GATA-2-/-mice, constructs
containing over one hundred kbp of genomic sequence
are required [8].
We have previously utilized bacterial artificial chromo-
somes (BACs), which can accommodate inserts contain-
ing several hundred kbp of genomic DNA[2,8,10-12], to
study regulation of GATA-2 in hematopoietic cells. Once
a genomic fragment has been cloned into a BAC, it can be
modified by insertion of a reporter gene[2,13-16]. Using
multiple GFP reporter modified BAC clones, containing
varied amounts of upstream and downstream genomic
sequence, we have demarcated a distal genomic region
that regulates hematopoietic GATA-2 expression in trans-
genic zebrafish [9].
In this report, we describe the identification and func-
tional studies of two highly conserved non-coding
sequence elements within this genomic region. Using Tol2
transposon cassettes containing these non-coding
sequence elements linked to GFP, we have identified a
224 bps cis-acting element that is sufficient to drive
reporter gene expression in a manner that recapitulates
hematopoietic  GATA-2  expression pattern in a stable
transgenic zebrafish line. In addition, deleting this ele-
ment from the modified BAC clone eliminates hemat-
opoietic GFP expression. Further analysis by base change
mutations coupled with transgenic analysis we demon-
strated that the HOXA3 and LMO2 play critical roles in
regulating GATA-2 hematopoietic expression.
Results
Comparative genomics analysis
The expression patterns of GATA-2 in hematopoietic and
neuronal tissues are conserved in vertebrates, suggesting
that the arrangement and sequence of the GATA-2
genomic locus may be highly conserved. Comparative
analyses of a158 kbp sequence spanning the zebrafish
GATA-2 locus and approximately 400 kbp sequences of
GATA-2 from human, mouse and rat and 190 Kb genomic
sequence flanking the fugu GATA-2 locus has revealed a
conserved syntenic relationship of GATA-2  with RPN1
(Figure 1A). A similar arrangement of general exon and
intron structures and high sequence homology in exons
has also been observed in the genomes of the five species
(Figure 1B). In addition, we have identified highly con-
served non-coding sequences in the genomicregion flank-
ing  GATA-2  (Figure 1A and 1B). We identified two
conserved non-coding sequences, one at ~13 and the
other ~10 kbp upstream of zebrafish GATA-2 start codon
(Figure 1A and 1B). These sequences are located in
approximately the same location in human, mouse, and
rat, but in fugu are located closer to the GATA-2 coding
sequence (4.7 Kbp and 3.8 Kbp, respectively). A conserved
non-coding sequence was also found downstream of
GATA-2  in fugu, mouse, rat, human and zebrafish
genomes (Figure 1A and 1B).
The conserved sequence located between12892-12811 bp
upstream of the zebrafish GATA-2 start codon (Up1) is 82
bp. Zebrafish Up1 sequence has an 81% sequence identity
with human Up1 sequence, an 80% sequence identity
with both mouse and rat Up1sequences and an 83%
sequence identity with that of fugu (Figure 1C). A con-
served sequence located 9887–10110 bp upstream of the
GATA-2  start codon (Up2) is 224 bp. Zebrafish Up2
sequence has a 74%, 72%, 72% and 94% sequence iden-
tity with Up2 sequences from human, mouse, rat and fugu
genomes, respectively (Figure 1C).
An alternative first exon (IS) has been found in the GATA-
2 genomic sequences of human, rodents and chick [17-
19]. In mouse genome, the conserved Up2 region (230
bp) is located at about 3 Kb 5' upstream of IS, which is
approximately 4.6 Kb further upstream of the general
exon IG of GATA-2 gene. To determine if alternative first
exons also exist in zebrafish, 5' RACE was performed using
mRNA from zebrafish embryos at the stages of 22~25
somites. As shown in Supplementary Figure S1 (see Addi-
tional file 1), only one PCR band was amplified, indicat-
ing that there is no alternative transcriptional product.
This finding is consistent with the data from analyzing
GATA-2 mRNA of 75% epiboly stage zebrafish embryos
reported by Oren et al [4]. Although zebrafish is different,
the genomic arrangement of IS among human, rodent
and chick genomes are conserved.
Functional analysis of the putative regulatory elements of 
GATA-2 gene in zebrafish
As noted, during zebrafish embryogenesis, GATA-2  is
expressed in the embryonic hematopoietic tissue Interme-
diate Cell Mass (ICM) and in neuronal cells (Figure 3A).
ICM specific gene expression of GATA-2 can be recapitu-
lated in transgenic zebrafish embryos carrying a GFP-
modified BAC construct that includes 20 kb genomicBMC Developmental Biology 2007, 7:97 http://www.biomedcentral.com/1471-213X/7/97
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Comparative Bioinformatics Analysis of GATA-2 Genomic loci Figure 1
Comparative Bioinformatics Analysis of GATA-2 Genomic loci. (A) A syntenic arrangement of GATA-2 (solid black 
arrow) and RPN1 (diagonal striped arrow) is conserved between human, mouse, fugu and zebrafish showing that these regions 
are orthologous. By sequence comparison, three evolutionarily conserved elements were identified in the human, mouse, rat, 
fugu and zebrafish genomes, two upstream of GATA-2, located at 12.9 kbp (Up1, open arrowhead) and 10 kbp (Up2, solid 
arrowhead), and one downstream of GATA-2 (Down1, black dot). (B) Zebrafish GATA-2 locus has 6 exons (blocks). An open 
arrowhead indicates the location of Up1; a solid arrowhead indicates the locations of Up2 in zebrafish genomic sequence flank-
ing GATA-2. Open blocks indicate the 5' UTR of zebrafish GATA-2; black blocks indicate zebrafish GATA-2 coding sequence. (C) 
Up1 stands for the genomic sequence lying 12892 bp to12811 bp upstream of the zebrafish GATA-2 start codon. The zebrafish 
Up1 sequence has an 81% sequence identity with the human Up1 sequence, an 80% sequence identity with both mouse and rat 
Up1sequences, and an 83% sequence identity with the fugu Up1 sequence. Up2 is the genomic sequence lying 10110 bp to 
9887 bp upstream of the zebrafish GATA-2 start codon. Up2a is genomic sequence lying 10110 bp to 9999 bp upstream of 
GATA-2 start codon; Up2b is the genomic sequence lying 9998 bp to 9887 bp upstream of GATA-2. The zebrafish Up2 sequence 
has a 74%, 72%, 72% and 94% sequence identity with Up2 sequences in the human, mouse, rat and fugu genomes, respectively.BMC Developmental Biology 2007, 7:97 http://www.biomedcentral.com/1471-213X/7/97
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sequence upstream of and adjacent to the GATA-2 start
codon (Figure 2B and 3B)[9]. In contrast, GFP expression
was not observed in the ICM of transgenic zebrafish
embryos carrying constructs containing only 7.3 kbp of
upstream sequence, although strong GFP expression was
seen in neuronal cells in these embryos (Figure 2C and
3C). These results indicate that a hematopoietic regulatory
element is located between 7.3 and 20 kbp upstream of
the zebrafish GATA-2 start codon.
To determine whether conserved non-coding sequences
located in this region, Up1 or Up2 are necessary, alone or
in combination, to drive hematopoietic expression, we
generated germline stable transgenic zebrafish carrying
modified BAC constructs having deletions of Up1 or Up2
or both. In progeny of transgenic zebrafish harboring
BACΔUp1/GFP, strong fluorescent expression was
observed in the ICM region at 24 hpf (Figure 2D and 3D).
GFP expression was stronger in embryos carrying
BACΔUp1/GFP than in transgenic zebrafish embryos car-
rying BAC/GFP (Figure 2B and 3B). GFP expression was
not observed in the ICM of embryos carrying BACΔUp2/
GFP (Figure 2E and 3E) or BACΔUp1ΔUp2/GFP (Figure
2F and 3F); however, GFP expression in neuronal cells
was not affected in these embryos (Figure 3E).
To determine whether these elements are sufficient, alone
or in combination, to induce hematopoietic expression,
GFP reporter gene constructs that contained Up1 or Up2
or both (Figure 2G–L) were used to generate transgenic
zebrafish. The conserved non-coding sequences found
12.9 kb and 10 kb, respectively, upstream of the GATA-2
start codon were inserted into Tol2-transposon cassettes
proximal to a GATA-2 minimal promoter/GFP fusion gen-
erating a series of construct combinations (Figure 2G~L).
These constructs were flanked by the Tol2 cis-acting ele-
ments, which are required for genome integration of the
construct. Each cassette was microinjected into fertilized
eggs containing maternally expressed Tol2 transposase.
Tol2-transposon mediated germline transmission of a
GATA-2  minimal promoter/GFP reporter gene fusion
(mp/GFP, Figure 2G) or of constructs with Up1, and/or
Up2, inserts (Figure 2H~L) was determined by PCR. This
approach, which typically produces at least 40% germline
transgenic zebrafish, resulted in multiple stable transgenic
zebrafish lines for each construct analyzed.
In zebrafish transgenic embryos carrying the Up1-mp/
GFP construct (N = 3) (Figure 2I), no ICM-specific expres-
sion was observed; however, strong fluorescence was
detected in the heart at 24 hpf (Figure 3G). In progeny of
three independent transgenic zebrafish lines carrying
Up2-mp/GFP, fluorescent expression was observed in
blastoderm cells at 80% epiboly (data not shown). At 24
hpf, in the same transgenic lines, strong GFP expression
was seen in the ICM, and weakly in the spinal cord (Figure
2J and 3H). The ICM expression pattern of Up2-mp/GFP
correlates well with GATA-2  expression pattern deter-
mined by in situ hybridization (Figure 3A). Two Up2 frag-
ments (112 bp Up2a and 112 bp Up2b, Figure 1C, Figure
2K and 2L) were also analyzed for the ability to drive
hematopoietic expression in transgenic zebrafish. In four
independent transgenic zebrafish lines, we found that
Up2a can drive GFP expression in the ICM although less
fluorescence was observed than in the Up2 transgenic and
Up2a transgenic zebrafish embryos also had non-specific
GFP expression in the notochord (Figure 2K and 3I). We
also obtained several lines of transgenic zebrafish carrying
a GFP expression vector in which both non-coding
sequence elements were linked to GATA-2 minimal pro-
moter (Figure 2H); GFP expression in the ICM and the
heart was observed at 24 hpf (data not shown). GFP
expression was undetectable in five independent trans-
genic zebrafish lines carrying GATA-2 minimal promoter
construct (Figure 2G).
Conservation of the non-coding sequence, Up2, in five
vertebrate species suggests functional conservation. To
determine whether this enhancer element is active in
mammalian hematopoietic cells, we performed transient
transfection assays with a construct containing Up2. We
transfected two human myeloid leukemia cell lines (KG-1
and K562) and a non-hematopoietic mammalian cell line
NIH 3T3, with the mp/GFP, Up2-mp/GFP and the Up2a-
mp/GFP constructs along with a CMV β-galactosidase
plasmid to normalize for transfection efficiency. In mye-
loid cell lines, we observed increased GFP expression and
this activity was stronger with the entire Up2 compared to
activity of the minimal promoter (Figure 4D). Transfec-
tion with the Up2a element also showed increased GFP
expression but this activity was less than that of the Up2.
In both cases, the differences were found to be statistically
significant when compared to the minimal promoter (Fig-
ure 4D). No GFP expression was observed in NIH3T3
cells; β-galactosidase expression was observed in this cell
line indicating that Up2 and Up2a enhancer activities are
specific to hematopoietic cells. Finally, we generated a
reporter construct containing the mouse Up2 linked to
GFP and analyzed its activity in transient transgenic
zebrafish assays. As shown in Supplementary Table S (see
additional file 2), mouse and zebrafish Up2 showed a
similar enhancer activity to direct hematopoietic expres-
sion of GFP.
Analysis of binding sites for potential transacting factors
Transfac6.0 Match and P-Match were used to search data-
bases[20] for potential transcription factor binding sites
involved in GATA-2 hematopoietic expression directed by
Up2 sequence. Multiple transcription factor binding sites
including those for AML1a, GATA-2, GATA-3, En-1, FAC1,BMC Developmental Biology 2007, 7:97 http://www.biomedcentral.com/1471-213X/7/97
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HNF-1, E2F-1, LMO2, ARP-1 and HOXA3 were identified.
Constructs carrying mutations on the binding sites for
transcription factor AML-1, E2F-1, ARP-1, LMO2 and
HOXA3 were generated and injected into zebrafish
embryo for transient assays of hematopoietic GFP expres-
sion. Under a condition that is statistically significant,
19.49% (n = 318), 21.79% (n = 335) and 22.09% (n =
335) of the embryos injected with construct carrying
mutation in E2F-1, LMO2 and HOXA3-A binding site,
respectively, showed transient hematopoietic GFP expres-
sion (Figure 4A and 4B). These percentages are signifi-
cantly lower than that of embryos injected with the
control Up2 construct (35.2%). Other constructs did not
show any significant differences (see additional file 2,
Supplementary Table S).
EMSA showed that, in vitro, proteins of transcription fac-
tors E2F-1 and HOXA3 specifically formed the protein-
DNA complexes with the probes containing LMO2 and
HOXA3-A binding sites present in Up2, respectively (Fig-
ure 4C). With the anti-E2F-1 antibody, a super shift was
observed while there was no super shift with a non-spe-
cific antibody. The shifted band was not observed with the
GATA-2 transgene constructs Figure 2
GATA-2 transgene constructs. (A) A schematic diagram of the zebrafish GATA-2 locus shows the first three exons and 
approximately 14 kbp of the genomic region upstream of GATA-2. (B) BAC/GFP: GFP modified BAC showing reporter GFP 
gene inserted before GATA-2 translational start codon. (C) GFP reporter gene construct contains a 7.3 kbp GATA-2 promoter. 
(D) BACΔUp1/GFP is a GFP modified zebrafish GATA-2 BAC having a deletion of the conserved non-coding sequence Up1. (E) 
BACΔUp2/GFP is a GFP modified GATA-2 BAC having a deletion of conserved non-coding sequence Up2. (F) BACΔUp1ΔUp2/
GFP is a GFP modified GATA-2 BAC having deletions of conserved non-coding sequences Up1 and Up2. (G) mp/GFP is a Tol2 
plasmid vector containing GFP linked to a GATA-2 minimal promoter, (H) Up1Up2-mp/GFP is a Tol2 plasmid vector containing 
Up1 and Up2 linked to mp/GFP, (I) Up1-mp/GFP is a Tol2 plasmid vector containing Up1 linked to mp/GFP, (J) Up2-mp/GFP is 
a Tol2 plasmid vector containing linked to mp/GFP, (K) Up2a-mp/GFP is a containing Up2a linked to mp/GFP, and (L) Up2b-mp/
GFP is a Tol2 plasmid vector containing Up2b linked to mp/GFP. In each Tol2 plasmid vector, GFP reporter gene constructs 
were inserted between Tol2 flanking sequences. Black block: Up1; Horizontal striped block: Up2; Open block: 5' UTR of 
zebrafish GATA-2 gene; Diagonal striped block: coding sequence of zebrafish GATA-2 gene.BMC Developmental Biology 2007, 7:97 http://www.biomedcentral.com/1471-213X/7/97
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GFP expression in GATA-2 transgenic zebrafish Figure 3
GFP expression in GATA-2 transgenic zebrafish. (A) Whole mount in situ hybridization shows GATA-2 mRNA expressed 
in zebrafish embryonic brain, ganglia cells, motor neurons and hematopoietic ICM region at 24 hpf stage. Arrows indicate the 
ICM. (B) Transgenic zebrafish carrying a modified BAC construct containing a 20 kb genomic sequence upstream of, and adja-
cent to the GATA-2 start codon show GFP expression in the ICM, brain and spinal cord at 24 hpf stage. (C) Transgenic 
zebrafish embryos carrying a GFP reporter gene construct linked to a 7.3 kb genomic sequence upstream of and adjacent to 
the GATA-2 start codon have strong GFP expression in neuronal cells, but not in the ICM at 24 hpf. (D) Transgenic zebrafish 
embryos carrying BACΔUp1/GFP have strong GFP expression in the ICM at 24 hpf stage. (E) Transgenic zebrafish embryos 
carrying BACΔUp2/GFP and (F) BACΔUp1ΔUp2/GFP have GFP expression in neuronal tissue but not in the ICM. (G) Trans-
genic zebrafish embryos carrying Up1-mp/GFP have strong GFP expression in the heart at 24 phf stage. (H) Stable transgenic 
zebrafish embryos containing the Up2 element linked with mp/GFP have strong GFP expression in the ICM and weak GFP 
expression in the spinal cord at 24 hpf stage. (I) Transgenic zebrafish embryos carrying Up2a-mp/GFP have GFP expression in 
ICM region at 24 hpf stage; non-specific GFP expression was observed the in notochord. (J-L) Transgenic zebrafish embryos 
carrying base change mutation in Up2 element derived from construct Up2-mp/GFP. (J) Mutation in the binding site of ARP1 
shows no effect on the GFP hematopoietic expression. (K) Mutation in the binding site of E2F-1 results in weaker GFP expres-
sion in ICM and strong non-specific expression in muscle and notochord. (L) Mutation in HOXA3-A binding site shows signifi-
cantly reduced GFP expression in ICM. Similar reduction of GFP in ICM was seen in LMO2 mutation (see Additional file 3, 
Supplementary Figure S2). White arrows indicate ICM expression of GFP.BMC Developmental Biology 2007, 7:97 http://www.biomedcentral.com/1471-213X/7/97
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Conservation of Up2 enhancer activity and transacting factors Figure 4
Conservation of Up2 enhancer activity and transacting factors. (A). Transient transgenic assays of hematopoietic GFP 
expression in embryos injected with wild type and mutant constructs identify HOXA3, LMO2 and E2F-1 as potential transcrip-
tion factors. Also see Additional file 2, Supplementary Table S for more information about the results of hematopoietic tran-
sient expression assay. (B). Typical transient GFP expression patterns in injected embryos at 22 hpf. Left, GFP expression is 
detected in hematopoietic cells (arrow); Right, non-specific GFP expression was observed in muscle, heart and neuron tissue 
but not in hematopoietic cells (C). EMSA shows transcription factor E2F-1 (left) and HOXA3 (right) specifically bind to the 
probe corresponding to Up2 sequence, respectively. Probe containing HOXA3-A binding site was analyzed in EMSA. (D). 
Human myeloid leukemia cell lines, KG1 and K562, and mouse fibroblast cell line, NIH3T3 were transiently transfected with 
the mp/GFP, Up2-mp/GFP and Up2a-mp/GFP constructs. GFP expression was stronger in myeloid cells than in the fibroblast 
cell line. In the myeloid cell lines, enhancer activity of Up2 and Up2a was found to be statistically significant (*p < 0.002, ^p < 
0.05, # p < 0.035, ** p < 0.032). The enhancer activity of Up2a/mp was less than that of Up2/mp. This figure represents the 
average of three independent experiments performed in duplicate.BMC Developmental Biology 2007, 7:97 http://www.biomedcentral.com/1471-213X/7/97
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probes containing a mutation in the E2F-1 and HOXA3-A
binding site, respectively.
The function of E2F-1, LMO2 and HOXA3 binding sites
were further analyzed in the germline transgenic zebrafish
embryos carrying the described base change mutations in
the same Up2-mp/GFP construct context. A base change
mutation in E2F-1 binding site showed increased non-
specific expression in muscle and notochord (Figure 3K)
and less severe but notably reduced expression in hemat-
opoietic cells. Mutation within LMO2 and HOXA3-A
binding sites resulted in almost elimination of GFP
expression in hematopoietic cells, showing a mosaic GFP
positive pattern in less than 10% of hematopoietic cells
compared to Up2-mp/GFP wild type construct (Figure 3L
and see additional file 3, Supplementary Figure S2). As a
control, mutation within the ARP-1 binding site showed
no effect on GFP expression (Figure 3J). These results
revealed that integrity of these putative LMO2 and
HOXA3-A binding sites is required for proper regulation
of GATA-2/GFP expression in hematopoietic cells.
Discussion
Due to important roles of GATA-2 in hematopoiesis
[1,8,9,21,22], a number of previous studies have been car-
ried out to analyze the cis-acting elements and transcrip-
tion factors that regulate hematopoietic GATA-2
expression. Transcription factors GATAs, Oct1 and Evi1
[4-6] and distal cis-acting DNA sequence elements appear
involved in regulating its hematopoietic expression as
revealed by transgenic animal studies [8,9]. The evolu-
tionary conservation of non-coding sequences indicates
that they have important biological functions, including
developmental regulation of gene expression [23,24]. We
used comparative genomics to identify three highly con-
served non-coding sequences in the genomic regions
flanking GATA-2  in the fugu, mouse, rat, human, and
zebrafish genomes. One conserved element is located
downstream, and two others, Up 1 and Up2, are located
upstream of GATA-2 in a genomic region that, we showed
in previous studies[9], is required for hematopoietic
expression of GATA-2 in transgenic zebrafish. In this study
we show that Up1 specifically directs GFP reporter gene
expression in heart and Up2 is required for hematopoietic
regulation of GATA-2. The enhancer activity of Up1 in
heart should represent an authentic activity since GATA-2
is expressed in the mouse heart [8] as well as weakly
expressed in embryonic zebrafish heart as detected by
whole mount mRNA in situ hybridization (unpublished
data).
Transgenic zebrafish carrying the Up2-mp/GFP construct
expressed GFP strongly in hematopoietic tissues, showing
that Up2 is sufficient to drive hematopoietic-specific gene
expression. In addition, BAC clones having a deletion of
Up2 did not drive hematopoietic gene expression whereas
deletion of Up1 had no impact on hematopoietic gene
expression, suggesting that Up2 is also necessary for regu-
lating  GATA-2  expression in hematopoietic tissues. In
transfection analyses, we also found that hematopoietic
Up2 enhancer activity is conserved in mammalian cells.
Similarly, mouse Up2 enhancer has directed higher
expression in zebrafish hematopoietic cells as shown by
transient assays (Figure 4A, and see additional file 2, Sup-
plementary table S), suggesting that function of Up2 is
conserved between zebrafish and mammals. The tissue-
specific expression in zebrafish appears to require ele-
ments that repress gene expression since deleting Up2b
results non-specific expression of GFP in notochord (Fig-
ure 3H). Interestingly, we have also observed this in the
regulation of the zebrafish GATA-1 gene [25].
Up2 contains several known consensus binding sites
including those for AML1a, GATA-2, GATA-3, En-1, FAC1,
HNF-1, E2F-1, LMO2 and HOXA3. Among these factors,
HOXA3, AML1a, E2F-1, ARP-1, LMO2 and GATA-1/3 are
likely to be involved in regulating hematopoietic GATA-2
expression since expression of the others has not been
observed in hematopoietic tissues. Several HOX genes
have recently been shown to be necessary for cdx4-medi-
ated specification of hematopoietic cell fate during verte-
brate embryogenesis[26]. Since specification of
hematopoietic cell fate precedes hematopoietic GATA-2
expression, HOXA proteins are good candidates for GATA-
2 regulation. E2F-1 and AML1a are also potential regula-
tors of hematopoietic GATA-2 expression. E2F-1 mouse
mutants have defects in hematopoietic progenitor cells
that result from impeded cell cycle progression[27].
AML1, also known as Runx1, contributes to both tran-
scriptional activation and repression in cell type-specific
hematopoietic gene expression; AML1  knock-out mice
lack fetal liver-derived hematopoietic cell clusters [28].
Furthermore, associated with chromosomal transloca-
tion, AML1 is involved in several types of acute myeloid
leukemia[29]. ARP-1 is a regulator of gene switching from
embryonic to fetal globins[30]. LMO2 forms transcription
factor complexes with SCL and GATA factors in erythroid
and hematopoietic progenitor cells[31]. GATA transcrip-
tion factor binding sites found in Up2 may be involved in
auto-regulation of GATA-2 expression by GATA-2[6] or
trans-regulation by other GATA factors. GATA-1 and
GATA-2 double knockdown in zebrafish did not elimi-
nate initial expression of GATA-2[32] (also, personal com-
munication from Zon LI, Children's Hospital, Boston).
Similarly, GATA-2 promoter driven GFP expression were
not affected in GATA-2-/- or GATA-3-/- null mouse embryos
[6]. We therefore focused on analyzing function of bind-
ing sites for other non-GATA factors within up2. From the
transgenic embryos injected with a series of site-specific
mutagenesis constructs of other potential transcriptionBMC Developmental Biology 2007, 7:97 http://www.biomedcentral.com/1471-213X/7/97
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binding sites contained in Up2, we demonstrated that the
mutations in putative E2F-1, LMO2 and HOXA3-A bind-
ing sites decreased hematopoietic GFP expression. There
are two high affinity HOXA3 binding sites in Up2 region.
Mutation of the HOXA3-B binding site did not affect the
hematopoietic expression of the GFP reporter gene, nei-
ther in transient nor in transgenic zebrafish embryos.
Interestingly, this HOXA3-B site is not conserved from
zebrafish to mammals. Thus, we consider the HOXA3-A
binding site is the conserved functional site. Although
mutations in the LMO2, E2F-1 and HOXA3-A binding
sites all affect GFP expression in hematopoietic cells,
LMO2 and HOXA3 sites appear playing a bigger role in
positive regulation of GATA-2 whereas E2F1 site is more
involved in restricting GATA-2 from expression in non-
hematopoietic cells. Further analysis of their correspond-
ing transcription factors by genetic and molecular
approaches may lead to a better understanding of mecha-
nisms underlying GATA-2  expression in hematopoietic
cells.
Up2 is located near at 10 kb 5' of start codon in both the
zebrafish and mouse GATA-2  gene. Previously, Koba-
yashi-Osaki et al. showed that a 26 base genomic
sequence element located immediately 5' upstream of the
conserved mouse up2 is essential for embryonic hemat-
opoietic expression of GATA-2/GFP in mouse [6]. In addi-
tion, five of six GATA binding sites scattered in a genomic
region of 336 bp, which encompass the up2 element, are
critical for GATA-2/GFP expression in transgenic mouse.
These observations, in addition to implicating roles of
GATA factors in regulating hematopoietic GATA-2 expres-
sion, conceivably validate the necessary function of up2 in
mouse. However, since expression of GATA-2/GFP is not
affected in either GATA-2-/-  or  GATA-3-/-  null mouse
mutant as well as GATA-2 expression is not affected when
both  GATA-1  and  GATA-2  are down regulated in
zebrafish, other factors may play more essential roles in
initiating embryonic GATA-2 hematopoietic expression.
Our studies suggest that factors binding to putative
HOXA3, LMO2 and E2F1 binding sites may be good can-
didates for such function. It is worth noting that the core
sequence of HOXA3, LMO2 and GATA binding sites share
high sequence similarity. Therefore the true identity of
transcription factors binding to these sites in vivo remains
as a subject of further investigation. Finally, mouse trans-
genic analysis suggests that a putative necessary enhancer
for complete hematopoietic expression is located between
100–150 kb 5' of GATA-2 [8]. It would be interesting to
determine in transgenic mouse if Up2 is also necessary by
deletion analysis of BAC or YAC constructs. If yes, it
would suggest that mouse needs additional enhancer
located even further away to facilitate function of Up2 ele-
ment in directing hematopoietic expression of GATA-2.
GATA-2 regulation in mouse and zebrafish may certain
differences reflecting evolutional divergence between the
two species. Nonetheless, Up2 is conserved in sequence
and genomic location and is functionally important in
zebrafish.
Although we focus on analyzing regulation of GATA-2
gene expression the approach described here, drawing on
embryological, genetic, molecular and computational
methods, is generally applicable for rapidly identifying
functional distal cis-acting sequences that regulate embry-
onic gene expression in vertebrates. In particular, we have
established a transgenic line that expresses Tol2 trans-
posase in germ cells, providing the transposase maternally
eliminates the need to co-inject transposase mRNA. This
simplified  Tol2  transposon-mediated transgenesis
approach allows generation of multiple stable transgenic
zebrafish lines with non-mosaic expression of the GFP
reporter gene. This study and a recent report by Fisher et
al [33] showed that Tol2 transposon vectors are extremely
useful for analyses of promoter and enhancer activity in
zebrafish.
Conclusion
A highly conserved 224 bp non-coding sequence (Up2)
located approximately 10 Kb 5' upstream of the zebrafish
GATA-2 is necessary and sufficient to direct hematopoietic
expression of GFP reporter gene. Within Up2 element,
binding sites for transacting factors HOXA3 and LMO2
appear important for its enhancer activity. Sequence sim-
ilarity of Up2 among zebrafish, mouse and human
genomes suggests function conservation.
Methods
Identification of highly conserved non-coding sequences in 
the genomic region bordering GATA-2
Pipmaker software was used to identify conserved non-
coding sequences in genomic sequences flanking GATA-2
in mouse, rat, human and fugu and that of the zebrafish
genome [34-36]. A 158 kbp zebrafish genomic sequence
(Sanger Institute accession number: AL928619, Figure 1)
was compared to orthologous regions of the other
genomes. The genomic sequences from other species used
for comparison were: rat chromosome 4 fragment
122,079,753 to 122,488,528 (~408 kbp); mouse chromo-
some 6 fragment 88,429,180 to 88,842,527 (~413 kbp);
human chromosome 3 fragment 129,480,974 to
129,894,726 (~413 kbp) and fugu scaffold_374 (~189
kbp).
Construction of Tol2 transposon vectors
Highly conserved zebrafish motifs (Up1, and Up2) iden-
tified by comparative genomics were amplified by PCR.
The primers used in the PCR reactions were:BMC Developmental Biology 2007, 7:97 http://www.biomedcentral.com/1471-213X/7/97
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Up1 5' primer: 5'-ATCCGCTCGAGTTTGACCTTTTCG-
GAAAACGAGCT-3'
Up1 3' primer: 5'-CGGAATTCTCTGATGGTCTCCACG-
GCAA-3'
Up2 5' primer: 5'-ATCCGCTCGAGATCTTCCCCCT-
CAAATGATGCA-3'
Up2 3' primer: 5'-CGGAATTCGGGGGTAATATTTCATCG-
GCGT-3'
Up2a 3' primer: 5'-CGGAATTCTGGAAACAGGGTC-
CAAAGT-3'
Up2b 5' primer: 5'-ATCCGCTCGAGCCTCGCTCGGTCCT-
GACA-3'
The underlined bases correspond to restriction enzyme
sites for Xho I (CTCGAG) or EcoR I (GAATTC); italicized
bases are zebrafish genomic sequences. PCR products
were digested with restriction enzymes Xho I and EcoR I
and inserted proximal to a GATA-2  minimal promoter
(mp)/GFP reporter gene contained in a Tol2 transposon
vector (Figure 2G~L). The GATA-2  minimal promoter
used is a 249 bp genomic sequence 5' proximal to the
GATA-2  transcription start site. The Tol2  vector, kindly
provided by Kochi Kawakami, was the original construct
previously described [37].
Base change or deletion mutations were introduced into
the putative binding sites of Up2 for transcription factors
E2F-1, ARP-1, AML-1, LMO2 and HOXA3, respectively,
using the mutagenesis kit from Strategene, Inc. (Catalog
No. 200521). The primers used for the site-directed muta-
genesis were:
AML-1 mF: 5'-ATTGAATGTATTTGCGAGAGCGGTTT-
GAAAAGGCGGCGA-3'
AML-1 mR: 5'-CCGCCTTTTCAAACCGCTCTCGCAAATA-
CATTCAATGCA-3'
ARP-1 mF: 5'-CACCAATTTATTCAGCGCCACGGGAGAC-
CCTGTTTCCAGCCT-3'
ARP-1 mR: 5'-AGGCTGGAAACAGGGTCTCCCGT-
GGCGCTGAATAAATTGGT-3'
E2F-1 mF: 5'-
CACCAATTTATTCAGC__ACTTTGGACCCTGTTTCC-3'
E2F-1 mR: 5'-
GGAAACAGGGTCCAAAGT__GCTGAATAAATTGGTG-3'
LMO2 mF: 5'-CCAGCGGTAAGCTACGCACGATTAG-
GCCATTTATTATCT-3'
LMO2 mR:5'-GTGAAGATAATAAATGGCCTAATCGT-
GCGTAGCTTACCG-3'
HOXA3-A mF: 5'-TTTGAAAAGGCGGCGATGGCCT-
GGGGGAGAGAGATAAG-3'
HOXA3-A mR: 5'-TTATCTCTCTCCCCCAG-
GCCATCGCCGCCTTTTCAAACC-3'
HOXA3-B mF: 5'-CCAGCGGTAAGCTGATAACGACCCG-
GCCATTTATTATCT-3'
HOXA3-B mR: 5'-GTGAAGATAATAAATGGCCGGGTCGT-
TATCAGCTTACC-3'
The underlined bases were the mutated sites. Three bases
were deleted from E2F-1 binding site (shown as a line).
Constructs carrying site-specific mutations were injected
into wild type zebrafish embryos at one cell stage. The
transient hematopoietic GFP expression was observed
under fluorescent microscope after 24 hpf to calculate the
percentage of hematopoietic GFP expression of each
mutated construct.
Construction of modified BAC constructs
BACs containing zebrafish GATA-2 identified in previous
studies were used in the construction of modified BAC
vectors[13,38]. Deletions of 5' upstream elements of
GATA-2  were preformed using the shuttle vector
pLD53.SCA_E_B as previously described [11,16]. In brief,
300~500 bp flanking sequences of Up1, or Up2, respec-
tively, were amplified by PCR. The primers used in dele-
tions of elements Up1 or Up2 or both were:
Up1 A box 5' primer: 5'-GCAT-
GGCGCGCCCCCCAAAAGTCACATCT-3'
Up1 A box 3' primer: 5'-CCGGTTAATTAATTCCGAAAAG-
GTCAAACACA-3'
Up1 B box 5' primer: 5'-CCGGTTAATTAAGA-
GAGCGCGCGCCCGGTGAAGAT-3'
Up1 B box 3' primer: 5'-CCGGATGGCCGGCCTACT-
TAACAACTCCAACCCA-3'
Up2 A box 5' primer: 5'-GCATGGCGCGCCACTGGA-
TAAAGGAGGCAA-3'
Up2 A box 3' primer: 5'-ACGTTTAATTAAGATCGCAT-
GGGGTGATAGAGACAG-3'
Up2 B box 5' primer: 5'-CCGGTTAATTAAAGAGAG-
GGCCCTGGCATCT-3'
Up2 B box 3' primer: 5'-CCGGATGGCCGGCCGTTCAAT-
GGACTCAAAAGGT-3'BMC Developmental Biology 2007, 7:97 http://www.biomedcentral.com/1471-213X/7/97
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The underlined bases correspond to restriction enzyme
sites for Asc I (GGCGCGCC), Pac I (TTAATTAA), or Fse I
(GGCCGGCC), and italicized bases are zebrafish genomic
sequences. PCR products were digested with restriction
enzymes, and ligated into pLD53.SCA_E_B lacking the
GFP reporter gene. The 5' flanking sequences were termed
A boxes while the 3' flanking sequences as B boxes. After
modification, the entire shuttle vector was integrated into
the GATA-2  BAC clone by homologous recombination
through one of the two homologous arms (A box or B
box). Selection in LB media containing 5.5% sucrose
resulted in deletions of Up1 or Up2 or both in approxi-
mately 50% of the BAC clones through recombination
with the second homologous arm (B box or A box). Dele-
tions were confirmed by sequencing.
The insertion of GFP into deletion and wild type GATA-2
BAC clones was carried out essentially as previously
described [39]. In brief, a 377 bp PCR product, (A box)
based on genomic sequence adjacent to and upstream of
the zebrafish GATA-2 start codon, was inserted into the
targeting vector pLD53.SC2 adjacent to a GFP reporter
gene. The primers used in PCR amplification were:
5' primer: 5'-GATCGGCGCGCCCGGTAGTTATTT-
GAAATTGCGA-3'
3' primer: 5'-CTCAAGTGTCCGCGCTTAGAAA-3'
Underlined bases in the 5' primer correspond to restric-
tion enzyme site for Asc I (GGCGCGCC) and italicized
bases are zebrafish genomic sequences. In the presence of
transiently expressed RecA, homologous recombination
took place between the A box in the vector and the A box
in the BAC clone resulting in integration of the vector
insert into the BAC clone, placing the GFP reporter gene
under control of the GATA-2 promoter within the clone
(Figure 2B, D~F).
Modified  GATA-2  B A C  c l o n e s  w e r e  i d e n t i f i e d  b y  P C R
using a forward primer (5'-CACGGGAAAAATAAACG-
CAGGA-3') upstream of the A box, and a reverse primer
located in the GFP sequence (5'-GCTGCTTCATGT-
GGTCGGGGTA-3'). PCR positive clones were further con-
firmed by comparison of digestion patterns with that of
the original BACs, or sequencing, or both.
Gel mobility shift analysis
EST clone BC076469 (cDNA clone MGC: 91782, IMAGE:
7039846), encoding zebrafish HOXA3, was purchased
from Open Biosystems, Inc. The ORF of HOXA3 was PCR
amplified with primers:
5' primer: 5'-ATCGAGGATCCACATTGGGAAACG-
GCGAG AT-3'
3' primer: 5'-AACAAAATACACTGCGCCA-3'
The underlined bases in the 5' primer contained the
BamH I restriction site. The PCR product was digested
with BamH I and cloned into the vector GEX-2T digested
with enzyme BamH I and Sma I to generate a HOXA3 in
frame fusion protein with GST. Plasmid containing the
GST-HOXA3 fusion protein was expressed in
BL21(DE3)plyYs. The construct containing fusion protein
of GST and human E2F-1 was a gift from Dr. Nevin's lab
at Duke University[40]. Protein expression and purifica-
tion were preformed as previously described[41].
Electrophoretic Mobility Shift Analysis (EMSA) was pre-
formed to confirm the binding affinity of the transcrip-
tional factors with Up2 sequence with non-radioactive gel
shift kit (Roche Applied Sciences, Inc. Catalog number:
03353591910). Complementary strand DNA oligoes con-
taining transcription factor E2F-1 and HOXA3-A binding
site, respectively, were annealed and DIG labeled. The
sequences are as follow:
HOXA3-A probe: 5'-GGTTTGAAAAGGCGGCGATAATCT-
GGGGGAGAGAGATAA-3'
E2F1 probe: 5'-ACACCAATTTATTCAGCGCCACTTT-
GGACCCTGTTTCCA-3'
Mouse monoclonal antibody KH95 (Abcom, Inc) was
used for super shift analysis and chicken anti-red fluores-
cent protein (RFP) polyclonal antibody (Chemicon Inter-
national, Inc. Catalog No. AB3528) was used as non-
specific antibody.
Generation of transgenic zebrafish
Tol2  vector-based plasmids were extracted and purified
using a Qiaprep Spin Miniprep Kit (Qiagen). Modified
BAC clone DNA was extracted using Hi-speed Maxi Prep
Kit (Qiagen). BAC DNA was digested with restriction
enzyme Not I and dialyzed in 0.5 × TE [13,14]. DNA con-
centrations were adjusted to ~100 ng/ul in 0.1 M KCl.
BAC construct DNA was microinjected into wild type
zebrafish fertilized eggs as previously described [38],
resulting 4–7% germline transmission. Tol2  constructs
were injected into transgenic zebrafish fertilized eggs con-
taining maternally expressed Tol2 transposase [37] driven
by the zebrafish vasa promoter [42]. F1 generation trans-
genic zebrafish embryos were identified by PCR. Fluores-
cent expression patterns were observed using a compound
fluorescent microscope (Axioplan Imaging, Zeiss). Photo-
graphs were captured using an AxioCam digital camera
(Zeiss), and Openlab software (Improvision).BMC Developmental Biology 2007, 7:97 http://www.biomedcentral.com/1471-213X/7/97
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Analysis of GFP reporter gene expression in mammalian 
cells lines
Transient transfection assays were performed in human
myeloid leukemia cell lines, KG1 and K562, and in mouse
fibroblasts NIH3T3. KG1 and K562 cells were cultured in
Iscoves media containing 10% fetal bovine serum (FBS),
2 mM/L L-glutamine, 100 U/ml Penicillin and 100 mg/
mL Streptomycin. NIH3T3 and 293T cells were cultured
in DMEM supplemented with 10% FBS, 2 mM/L L-
glutamine, 100 U/ml Penicillin and 100 mg/mL Strepto-
mycin. Fifteen micrograms of GATA-2/GFP fusion con-
structs were co-transfected with 5 ug of the CMV-β-
galactosidase plasmids into mammalian cells by electro-
poration as previously described[43,44]. Forty-eight
hours after transfection, cells were harvested and β-galac-
tosidase activity was measured using the Promega assay
kit (Promega). GFP expression levels were determined
using flow cytometry. 106 Cells were harvested, washed,
and resuspended in phosphate-buffered saline (PBS) and
analyzed using a FACS-SCAN cytometer (Beckton-Dickin-
son). The percentage of GFP positive cells was calculated
using cell quest software and expression levels were nor-
malized using CMV-β-galactosidase activity. P values were
calculated using the Student-T test method and Jump In
software.
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